{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:42:37Z","timestamp":1778593357900,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010983","name":"Region Midtjyllands Sundhedsvidenskabelige Forskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010983","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.radonc.2024.110149","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:45:08Z","timestamp":1707439508000},"page":"110149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Tumor volume and cancer stem cell expression as prognostic markers for high-dose loco-regional failure in head and neck squamous cell carcinoma \u2013 A DAHANCA 19 study"],"prefix":"10.1016","volume":"193","author":[{"given":"Morten Horsholt","family":"Kristensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mia Kristina","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3894-4552","authenticated-orcid":false,"given":"Trine","family":"Tramm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5395-3193","authenticated-orcid":false,"given":"Jan","family":"Alsner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brita Singers","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9698-2082","authenticated-orcid":false,"given":"Christian","family":"Maare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3911-3929","authenticated-orcid":false,"given":"J\u00f8rgen","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Primdahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5se","family":"Bratland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus Andrup","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob Kinggaard","family":"Lilja-Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Ivalu Sander","family":"Holm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8011-669X","authenticated-orcid":false,"given":"Eva","family":"Sams\u00f8e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian R\u00f8nn","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruta","family":"Zukauskaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper Grau","family":"Eriksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110149_b0005","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrc.2016.18","article-title":"Radiation oncology in the era of precision medicine","volume":"16","author":"Baumann","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2024.110149_b0010","first-page":"1","article-title":"Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV -positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts","author":"Lassen","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2024.110149_b0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.radonc.2011.03.004","article-title":"Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck - A systematic review and meta-analysis","volume":"100","author":"Overgaard","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110149_b0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0167-8140(23)08519-5","article-title":"OC-0105 Incidence and survival after HPV+ and HPV- oropharynx cancer in Denmark 1986\u20132020 - A DAHANCA study","volume":"182","author":"Lassen","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110149_b0025","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","article-title":"Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis","volume":"368","author":"Bourhis","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2024.110149_b0030","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S1470-2045(17)30458-8","article-title":"Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis","volume":"18","author":"Lacas","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110149_b0035","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1470-2045(21)00076-0","article-title":"Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis","volume":"22","author":"Petit","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110149_b0040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2017.11.024","article-title":"Local recurrences after curative IMRT for HNSCC: Effect of different GTV to high-dose CTV margins","volume":"126","author":"Zukauskaite","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110149_b0045","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/09553000902836404","article-title":"Cancer stem cells and radiotherapy","volume":"85","author":"Baumann","year":"2009","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.radonc.2024.110149_b0050","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrc2419","article-title":"Exploring the role of cancer stem cells in radioresistance","volume":"8","author":"Baumann","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2024.110149_b0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addr.2016.02.002","article-title":"Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments","volume":"109","author":"Krause","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.radonc.2024.110149_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2019.02.016","article-title":"Diversity of cancer stem cells in head and neck carcinomas: The role of HPV in cancer stem cell heterogeneity, plasticity and treatment response","volume":"135","author":"Reid","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110149_b0065","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.scr.2013.02.004","article-title":"CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell properties","volume":"10","author":"Martens-de Kemp","year":"2013","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.radonc.2024.110149_b0070","first-page":"13","article-title":"Tyrosine kinase C-MET as therapeutic target for radiosensitization of head and neck squamous cell carcinomas","author":"L\u00fcttich","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2024.110149_b0075","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1002\/ijc.25927","article-title":"Head neck squamous cell carcinoma c-Met+ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis","volume":"129","author":"Sun","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2024.110149_b0080","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1073\/pnas.0610117104","article-title":"Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma","volume":"104","author":"Prince","year":"2007","journal-title":"PNAS"},{"key":"10.1016\/j.radonc.2024.110149_b0085","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.radonc.2016.11.008","article-title":"HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation","volume":"121","author":"Linge","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110149_b0090","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1158\/1078-0432.CCR-15-1990","article-title":"Low cancer stem cell marker expression and low hypoxia identify good prognosis subgroups in HPV(-) HNSCC after postoperative radiochemotherapy: A multicenter study of the DKTK-ROG","volume":"22","author":"Linge","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2024.110149_b0095","first-page":"40","article-title":"Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy","volume":"16","author":"Linge","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110149_b0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0167-8140(97)00215-6","article-title":"Tumor volume: A basic and specific response predictor in radiotherapy","volume":"47","author":"Dubben","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110149_b0105","doi-asserted-by":"crossref","unstructured":"Overgaard J, Hansen HS, Jorgensen K, Hansen MH, Fh D. Primary radiotherapy of larynx and pharynx carcinoma\u2014An analysis of some factors influencing local control and survival 1986;12:515\u201321.","DOI":"10.1016\/0360-3016(86)90058-1"},{"key":"10.1016\/j.radonc.2024.110149_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-022-02074-7","article-title":"Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy","volume":"17","author":"Adrian","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110149_b0115","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/MLG.0b013e318172c82c","article-title":"Tumor volume as a prognostic factor in oropharyngeal squamous cell carcinoma treated with primary radiotherapy","volume":"118","author":"Been","year":"2008","journal-title":"Laryngoscope"},{"key":"10.1016\/j.radonc.2024.110149_b0120","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00066-018-1309-z","article-title":"Tumor volume as a prognostic marker in p16-positive and p16-negative oropharyngeal cancer patients treated with definitive intensity-modulated radiotherapy","volume":"194","author":"Carp\u00e9n","year":"2018","journal-title":"Strahlentherapie Und Onkol"},{"key":"10.1016\/j.radonc.2024.110149_b0125","doi-asserted-by":"crossref","first-page":"E60","DOI":"10.1002\/lary.25567","article-title":"Tumor volume as a prognostic factor for local control and overall survival in advanced larynx cancer","volume":"126","author":"Timmermans","year":"2016","journal-title":"Laryngoscope"},{"key":"10.1016\/j.radonc.2024.110149_b0130","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1016\/S0167-8140(18)30581-4","article-title":"5-Y update of the randomized phase III trial DAHANCA19: Primary (Chemo) RT +\/- zalutumumab in HNSCC","volume":"127","author":"Eriksen","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110149_b0135","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2147\/CLEP.S103591","article-title":"The Danish head and neck cancer database","volume":"8","author":"Overgaard","year":"2016","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.radonc.2024.110149_b0140","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1080\/0284186X.2023.2270143","article-title":"A national repository of complete radiotherapy plans: design, Results, and experiences","volume":"62","author":"Krogh","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2024.110149_b0145","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3109\/0284186X.2016.1167959","volume":"55","author":"Toustrup","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2024.110149_b0150","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1080\/0284186X.2019.1660802","article-title":"Characterization and radiosensitivity of HPV-related oropharyngeal squamous cell carcinoma patient-derived xenografts","volume":"58","author":"Lilja-Fischer","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2024.110149_b0155","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1158\/0008-5472.CAN-11-1182","article-title":"Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer","volume":"71","author":"Toustrup","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2024.110149_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrrev.2021.108374","article-title":"CD44 polymorphisms and its variants, as an inconsistent marker in cancer investigations. Mutat Res - Rev","volume":"787","author":"Gomari","year":"2021","journal-title":"Mutat Res"},{"key":"10.1016\/j.radonc.2024.110149_b0165","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.radonc.2012.09.017","article-title":"Scoring and classification of oropharyngeal carcinoma based on HPV-related p16-expression","volume":"105","author":"Lassen","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110149_b0170","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","author":"Lawrence","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.radonc.2024.110149_b0175","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.radonc.2014.11.032","article-title":"Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer","volume":"113","author":"Lassen","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110149_b0180","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejca.2013.11.010","article-title":"Cancer stem cell enrichment marker CD98: A prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer","volume":"50","author":"Rietbergen","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2024.110149_b0185","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/jop.12478","article-title":"Combined CD44, c-MET, and EGFR expression in p16-positive and p16-negative head and neck squamous cell carcinomas","volume":"46","author":"Baschnagel","year":"2017","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.radonc.2024.110149_b0190","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00066-020-01653-5","article-title":"Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC","volume":"197","author":"Jakob","year":"2021","journal-title":"Strahlentherapie Und Onkol"},{"key":"10.1016\/j.radonc.2024.110149_b0195","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/s41416-022-01730-9","article-title":"Prognostic and predictive roles of cancer stem cell markers in head and neck squamous cell carcinoma patients receiving chemoradiotherapy with or without nimotuzumab","volume":"126","author":"Patel","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2024.110149_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2019.01470","article-title":"Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation","volume":"9","author":"van der Heijden","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2024.110149_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-023-04439-2","article-title":"Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts","volume":"21","author":"Koi","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.radonc.2024.110149_b0210","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.semcancer.2014.06.004","article-title":"A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms","volume":"31","author":"Cojoc","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.radonc.2024.110149_b0215","article-title":"Tumor volume as prognostic factor in chemoradiation for advanced head and neck cancer","volume":"36","author":"Knegjens","year":"2010","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2024.110149_b0220","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.ijrobp.2010.10.053","article-title":"Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy","volume":"82","author":"Strongin","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110149_b0225","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.radonc.2022.09.023","article-title":"Larynx cancer survival model developed through open-source federated learning","volume":"176","author":"R\u00f8nn Hansen","year":"2022","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024000707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024000707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:28:44Z","timestamp":1759123724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024000707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":45,"alternative-id":["S0167814024000707"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110149","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor volume and cancer stem cell expression as prognostic markers for high-dose loco-regional failure in head and neck squamous cell carcinoma \u2013 A DAHANCA 19 study","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110149"}}